Remove Innovation Remove Plaque Remove Technology
article thumbnail

Abbott Enters IVL Burgeoning Segment

CardiacWire

IVL is a minimally invasive medical catheter-based procedure that treats calcified plaque in blood vessels. The Takeaway Shockwave might have a decade head start, but it appears that the cardio-medtech industry has woken up to the potential of IVL, and this much competition is likely to breed innovation that benefits patients.

Plaque 59
article thumbnail

Philips Enrolls First Patient in Clinical Trial for Integrated Single-Device to Treat PAD

DAIC

THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter that integrates two critical PAD treatments into a single device. The innovative feature of the Philips catheter is that both the atherectomy and lithotripsy are laser-driven. clinical trial,” said Dr.

article thumbnail

Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte Image Guided Crossing and Re-Entry Catheter System

DAIC

a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ).

article thumbnail

Elixir Medical Granted FDA Breakthrough Device Designation for DynamX Bioadaptor

DAIC

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. This restores the vessel viability and hemodynamic modulation by returning pulsatility, compliance, adaptive blood flow volume, and plaque stabilization and regression.

article thumbnail

Artificial Intelligence Helps Coronary CT Angiography and Accelerates the Development of Precision Medicine

DAIC

With the continuous progress of science and technology, artificial intelligence (AI) has become an important driving force for a new round of scientific and technological revolution and industrial change. ©Science China Press milla1cf Wed, 01/17/2024 - 16:04 January 17, 2024 — This review was jointly published by Prof.

article thumbnail

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

DAIC

According to the company, Earls is a leader within the field of radiology and specializes in applications of advanced imaging technologies in cardiovascular care. He is the author of over 150 articles, book chapters, abstracts and other publications on advanced imaging technologies. With Plaque Features Associated with False Positives.

article thumbnail

HeartFlow Achieves Landmark Milestone of 250,000 Patients Assessed for Coronary Artery Disease (CAD) with FFRCT Analysis

DAIC

7 While HeartFlow was founded with FFR CT technology, the company has evolved from a single product used to assess the impact that narrowing vessels have on coronary blood flow (FFR CT Analysis), to a comprehensive suite of non-invasive technologies that build on CCTA. said John Farquhar, Chief Executive Officer at HeartFlow.